The redevelopment of CRISPR/Cas9 technology has dramatically increased our ability to edit the human genome, allowing for targeted genetic modifications of human gametes and embryos. CRISPR's therapeutic potential is vast, but this new technology also raises profound ethical questions: How will CRISPR-based biomedical research affect human life, especially at its earliest stages? And will it affirm or undermine the dignity of the human person?
Lunch will be provided. Those wishing to attend should RSVP to Patrick Hough.
William Hurlbut is a physician and Consulting Professor in the Department of Neurobiology at Stanford University Medical Center.